Colors on your screen may differ slightly from real ones due to your screen configuration and screen type.
Dr. Yudina Terebinthine mask 50ml №4 Terabentin Mask
Product look may be differ from actual one due to manufacturer design changes over time!
Colors on your screen may differ slightly from real ones due to your screen configuration and screen type.
Product look may be differ from actual one due to manufacturer design changes over time!
Terabentine Mask No. 4 is a professional care product for the treatment of such diseases: Acne (moderate and severe), rosacea, eczema, seborrheic, perioral, acneiform dermatitis; for the prevention and correction of post-acne. Dr. Yudina Terabentine Mask No. 4 is paraben and allergen-free, with antibacterial and antiparasitic properties.
Dr. Yudina Terabentine Mask contains unique natural ingredients: tar, turpentine, sulfur, zinc, salicylic acid. The optimal combination of active ingredients allowed us to create a multifunctional product with keratolytic, sebum-regulating, comedolytic, antibacterial, antiparasitic, regenerating and soothing effects.
The mask stabilizes the inflammatory process and suppresses the formation of new rash elements.
Apply a thin layer once a day for 10 minutes (a feeling of discomfort - burning and tingling - may occur). Rinse with water, apply Sebo-norma cream or Treatment Gel No. 2.
Petrolatum, Zinc Oxide, Sulfur, Paraffinum Liquidum, Betula Alba Oil, Oleum Terebinthinae Rectificatum, Metronidazole, Salicylic Acid.
| Sex | For women |
| Time of use | Universal |
| Type of skins | Oily, Combined, Problematic |
| Functions | From Acne, Antibacterial, Antioxidant action, Sedation |
| Area of use | Face |
| Volume | 50ml |
| Brand | Dr. Yudina |
| Serie | Medical - Medical series |
| Country of ™ | Ukraine |
| Categories | Skin Care - Masks for face |
The information on technical characteristics, the delivery set, the country of manufacture and the appearance of the goods is of a reference nature and is based on the latest information available at the time of publication.
Loading...